Mechanism of tau-induced neurodegeneration in Alzheimer disease and related tauopathies

被引:97
|
作者
Alonso, Alejandra del C. [1 ,2 ]
Li, Ben [3 ]
Grundke-Iqbal, Inge [3 ]
Iqbal, Khalid [3 ]
机构
[1] CUNY, Coll Staten Isl, Dept Biol, Staten Isl, NY 10314 USA
[2] CUNY, Coll Staten Isl, Ctr Dev Neurosci & Dev Disabil, Staten Isl, NY 10314 USA
[3] New York State Inst Basic Res Dev Disabil, Staten Isl, NY 10314 USA
关键词
D O I
10.2174/156720508785132307
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The accumulation of hyperphosphorylated tau is a common feature of several dementias. Tau is one of the brain microtubule-associated proteins. Here we discuss tau's function in microtubule assembly and stabilization and with regards to tau's interactions with other proteins, membranes, and DNA. We describe and analyze important posttranslational modifications: hyperphosphorylation, glycosylation, ubiquitination, glycation, polyamination, nitration, and truncation. We discuss how these post-translational modifications can alter tau's biological function and what is known about tau self-assembly, and we propose a mechanism of tau polymerization. We analyze the impact of natural mutations on tau that cause fronto-temporal dementia associated with chromosome 17 (FTDP-17). Finally, we consider whether tau accumulation or its conformational change is related to tau-induced neurodegeneration, and we propose a mechanism of neurodegeneration.
引用
收藏
页码:375 / 384
页数:10
相关论文
共 50 条
  • [21] Tau-focused therapy and tau transmission: Implications for Alzheimer’s Disease and related tauopathies
    John Q Trojanowski
    Molecular Neurodegeneration, 8 (Suppl 1)
  • [22] Hippocampal tau-induced GRIN3A deficiency in Alzheimer's disease
    Lee, Sang-Eun
    Park, Soomin
    Kang, Rian
    Lee, Taehoon
    Yu, Won Jong
    Chang, Sunghoe
    Park, Jong-Chan
    FEBS OPEN BIO, 2024, 14 (12): : 2059 - 2071
  • [23] Tau focused drug discovery for Alzheimer's disease and related Neuroclegenerative Tauopathies
    Lee, Virginia M. -Y
    Trojanowski, John Q.
    ALZHEIMER: 100 YEARS AND BEYOND, 2006, : 333 - +
  • [24] Cerebral Microvascular Accumulation of Tau Oligomers in Alzheimer's Disease and Related Tauopathies
    Castillo-Carranza, Diana L.
    Nilson, Ashley N.
    Van Skike, Candice E.
    Jahrling, Jordan B.
    Patel, Kishan
    Garach, Prajesh
    Gerson, Julia E.
    Sengupta, Urmi
    Abisambra, Jose
    Nelson, Peter
    Troncoso, Juan
    Ungvari, Zoltan
    Galvan, Veronica
    Kayed, Rakez
    AGING AND DISEASE, 2017, 8 (03): : 257 - 266
  • [25] Heterogeneous Tau Oligomers as Molecular Targets for Alzheimer's Disease and Related Tauopathies
    Lo, Chih Hung
    BIOPHYSICA, 2022, 2 (04): : 440 - 451
  • [26] Immunotherapy Targeting Pathological Tau Protein in Alzheimer's Disease and Related Tauopathies
    Sigurdsson, Einar M.
    JOURNAL OF ALZHEIMERS DISEASE, 2008, 15 (02) : 157 - 168
  • [27] Tau Immunotherapies for Alzheimer's Disease and Related Tauopathies: Progress and Potential Pitfalls
    Sigurdsson, Einar M.
    JOURNAL OF ALZHEIMERS DISEASE, 2018, 64 : S555 - S565
  • [28] Neurodegeneration and Alzheimer's disease: the lesson from tauopathies
    Sorrentino, G.
    Bonavita, V.
    NEUROLOGICAL SCIENCES, 2007, 28 (02) : 63 - 71
  • [29] Neurodegeneration and Alzheimer’s disease: the lesson from tauopathies
    G. Sorrentino
    V. Bonavita
    Neurological Sciences, 2007, 28 : 63 - 71
  • [30] Hyperphosphorylated tau (p-tau) and drug discovery in the context of Alzheimer's disease and related tauopathies
    Moore, Kendall B. E.
    Hung, Ta-Jung
    Fortin, Jessica S.
    DRUG DISCOVERY TODAY, 2023, 28 (03) : 1 - 15